PMC:7212965 / 40319-40456 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T207","span":{"begin":121,"end":129},"obj":"Disease"}],"attributes":[{"id":"A207","pred":"mondo_id","subj":"T207","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"}],"text":" receiving lopinavir/ritonavir, there were 9.5% (9 of 99) with nausea, 6.3% (6 of 99) with vomiting, 4.2% (4 of 99) with diarrhea, 4.2% ("}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T83","span":{"begin":11,"end":30},"obj":"Chemical"},{"id":"T84","span":{"begin":11,"end":20},"obj":"Chemical"},{"id":"T85","span":{"begin":21,"end":30},"obj":"Chemical"}],"attributes":[{"id":"A83","pred":"chebi_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A84","pred":"chebi_id","subj":"T84","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A85","pred":"chebi_id","subj":"T85","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"}],"text":" receiving lopinavir/ritonavir, there were 9.5% (9 of 99) with nausea, 6.3% (6 of 99) with vomiting, 4.2% (4 of 99) with diarrhea, 4.2% ("}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T180","span":{"begin":63,"end":69},"obj":"Phenotype"},{"id":"T181","span":{"begin":91,"end":99},"obj":"Phenotype"},{"id":"T182","span":{"begin":121,"end":129},"obj":"Phenotype"}],"attributes":[{"id":"A180","pred":"hp_id","subj":"T180","obj":"http://purl.obolibrary.org/obo/HP_0002018"},{"id":"A181","pred":"hp_id","subj":"T181","obj":"http://purl.obolibrary.org/obo/HP_0002013"},{"id":"A182","pred":"hp_id","subj":"T182","obj":"http://purl.obolibrary.org/obo/HP_0002014"}],"text":" receiving lopinavir/ritonavir, there were 9.5% (9 of 99) with nausea, 6.3% (6 of 99) with vomiting, 4.2% (4 of 99) with diarrhea, 4.2% ("}

{"project":"LitCovid-PubTator","denotations":[{"id":"1150","span":{"begin":11,"end":30},"obj":"Chemical"},{"id":"1155","span":{"begin":63,"end":69},"obj":"Disease"},{"id":"1156","span":{"begin":91,"end":99},"obj":"Disease"},{"id":"1157","span":{"begin":121,"end":129},"obj":"Disease"}],"attributes":[{"id":"A1150","pred":"tao:has_database_id","subj":"1150","obj":"MESH:C558899"},{"id":"A1155","pred":"tao:has_database_id","subj":"1155","obj":"MESH:D009325"},{"id":"A1156","pred":"tao:has_database_id","subj":"1156","obj":"MESH:D014839"},{"id":"A1157","pred":"tao:has_database_id","subj":"1157","obj":"MESH:D003967"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" receiving lopinavir/ritonavir, there were 9.5% (9 of 99) with nausea, 6.3% (6 of 99) with vomiting, 4.2% (4 of 99) with diarrhea, 4.2% ("}